A glowing capsule on the right side of a grey background. The left half of the capsule is white, while the right half contains electric wires in blue — First Opinion coverage from STAT Meyers is executive vice president and chief digital and technology officer at Bristol Myers Squibb. The acceleration of artificial intelligence is arriving just in time for the biopharmaceutical industry. The global demand for innovative, effective treatments is growing faster than ever as the world’s largest drugmakers face intensifying regulatory, pricing, and political pressure. In this challenging environment, traditional industry processes must simply move faster. advertisement The good news: AI is starting to unlock the progress the industry needs. BMS and our peers are using AI tools to reinvent pharma right now, which is helping patients […]
Original web page at www.statnews.com
